|
|
||||||||
Departments of 1 Pharmacological Research I, 2 Assay and Cell Technology, and 3 Histology, Novo Nordisk, DK-2880 Bagsvaerd, Denmark; and 4 Department of Pharmacology and Pathobiology, Royal Veterinary and Agricultural University, DK-1870 Copenhagen, Denmark
Nonrodent models of diabetes are needed
for practical and physiological reasons. Induction of mild
insulin-deficient diabetes was investigated in male Göttingen
minipigs by use of streptozotocin (STZ) alone (75, 100, and 125 mg/kg)
or 125 mg/kg combined with pretreatment with nicotinamide (NIA; 0, 20, 67, 100, 150, and 230 mg/kg). Use of NIA resulted in a less steep slope
of the regression line between fasting plasma glucose and changing
doses compared with STZ [
7.0 ± 1.4 vs. 29.7 ± 7.0 mM · mg
1 · kg
1,
P < 0.0001]. Intermediate NIA doses induced moderate
changes of glucose tolerance [glucose area under the curve increased
from 940 ± 175 to 1,598 ± 462 mM · min,
P < 0.001 (100 mg/kg) and from 890 ± 109 to
1,669 ± 691 mM · min, P = 0.003 (67 mg/kg)] with reduced insulin secretion [1,248 ± 602 pM · min after 16 days and 1,566 ± 190 pM · min
after 60 days vs. 3,251 ± 804 pM · min in normal animals
(P < 0.001)] and
-cell mass [5.5 ± 1.4 mg/kg after 27 days and 7.9 ± 4.1 mg/kg after 60 days vs.
17.7 ± 4.7 mg/kg in normal animals (P = 0.009)].
The combination of NIA and STZ provided a model characterized by
fasting and especially postprandial hyperglycemia and reduced, but
maintained, insulin secretion and
-cell mass. This model holds
promise as an important tool for studying the pathophysiology of
diabetes and development of new pharmacological agents for treatment of
the disease.
in vivo pharmacology; large-animal model; glucose tolerance;
-cell reduction; glucose-stimulated insulin secretion.
This article has been cited by other articles:
![]() |
B. Christoffersen, U. Ribel, K. Raun, V. Golozoubova, and G. Pacini Evaluation of different methods for assessment of insulin sensitivity in Gottingen minipigs: introduction of a new, simpler method Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1195 - R1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. CHATZIGEORGIOU, A. HALAPAS, K. KALAFATAKIS, and E. KAMPER The Use of Animal Models in the Study of Diabetes Mellitus In Vivo, March 1, 2009; 23(2): 245 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Larsen, B. Rolin, J. Sturis, M. Wilken, R. D. Carr, N. Porksen, and C. F. Gotfredsen Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Gottingen minipigs in vivo Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E670 - E677. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pold, L. S. Jensen, N. Jessen, E. S. Buhl, O. Schmitz, A. Flyvbjerg, N. Fujii, L. J. Goodyear, C. F. Gotfredsen, C. L. Brand, et al. Long-Term AICAR Administration and Exercise Prevents Diabetes in ZDF Rats Diabetes, April 1, 2005; 54(4): 928 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Larsen, C. B. Juhl, N. Porksen, C. F. Gotfredsen, R. D. Carr, U. Ribel, M. Wilken, and B. Rolin {beta}-Cell function and islet morphology in normal, obese, and obese {beta}-cell mass-reduced Gottingen minipigs Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E412 - E421. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Brand, J. Sturis, C. F. Gotfredsen, J. Fleckner, C. Fledelius, B. F. Hansen, B. Andersen, J.-M. Ye, P. Sauerberg, and K. Wassermann Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E841 - E854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Larsen, B. Rolin, M. Wilken, R. D. Carr, and C. F. Gotfredsen Measurements of Insulin Secretory Capacity and Glucose Tolerance to Predict Pancreatic {beta}-Cell Mass In Vivo in the Nicotinamide/Streptozotocin Gottingen Minipig, a Model of Moderate Insulin Deficiency and Diabetes Diabetes, January 1, 2003; 52(1): 118 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Christoffersen, J. P. Goetze, E. D. Bartels, M. O. Larsen, U. Ribel, J. F. Rehfeld, B. Rolin, and L. B. Nielsen Chamber-Dependent Expression of Brain Natriuretic Peptide and Its mRNA in Normal and Diabetic Pig Heart Hypertension, July 1, 2002; 40(1): 54 - 60. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |